Apr 13, 2006
Letter to Shareholders of Hemispherx Biopharma, Inc. from William A. Carter, M.D., Chairman of the Board and Chief Executive Officer

Apr 11, 2006
HEMISPHERX BIOPHARMA TO HOST CONFERENCE CALL TO REVIEW COMPANY'S ACCOMPLISHMENTS, UPDATE ON INFLUENZA RELATED STUDIES AND OUTLINE FUTURE GOALS

Apr 07, 2006
Hemispherx Biopharma, Inc. Late Filing of Form 10-K Generates Standard Non-Compliance Notification From The AMEX

Apr 03, 2006
Hemispherx Biopharma, Inc. Announces Delay in Filing Its Form 10-K for the Fiscal Year Ended December 31, 2005

Mar 16, 2006
New Research From Hemispherx Biopharma Leverages Recent Studies to Identify Factors in Breakdown of Immune System; May Help Prevent Spread of Avian Flu

Feb 16, 2006
3 New Studies Show Hemispherx Biopharma's Ampligen® and Alferon® LDO May Provide Defense Against Avian Flu

Jan 03, 2006
HEMISPHERX BIOPHARMA LETTER TO SHAREHOLDERS

Dec 20, 2005
Hemispherx to Present at the 4th Annual Biodefense Research Meeting Sponsored by the American Society of Microbiology, Ampligen® and Alferon® in Global Clinical / Animal Trials Against Avian Influenza

Dec 13, 2005
Hemispherx Highlighted in Study of Innate Immunity As a Defense Against Bio-terror Threats,

Dec 12, 2005
HEMISPHERX BIOPHARMA TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 9TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE

 54   55   56   57   58     59    60   61   62   63   64